Adial Pharmaceuticals, Inc

ADILNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
3.13 USD
↗ 0.97 (45.00%)🟢LIVE (AS OF 03:17 PM EDT)
🟢Market: OPEN

Adial Pharmaceuticals, Inc (ADIL) trades at $3.13 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, ADIL appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 10, 2026.

Open?$2.28
High?$4.96
Low?$2.14
Prev. Close?$2.16
Volume?19.7M
Avg. Volume?154.1K
VWAP?$3.78
Rel. Volume?127.69x
Bid / Ask
Bid?$3.06 × 100
Ask?$3.10 × 100
Spread?$0.04
Midpoint?$3.08
Valuation & Ratios
Market Cap?4.6M
Shares Out?2.1M
Float?1.4M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$3.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
6
Market Cap
4.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.adial.com
Listed
2018-07-27
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
86
Piotroski F-Score?0/9Weak
Altman Z-Score?-26.80Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.36%Low
Short Interest?47.3K
Days to Cover?1.0
Free Float1.4M
Avg Daily Volume350.1K
Settlement Date2026-05-29
Financial Health
Current Ratio?3.18Strong
Quick Ratio?3.18Strong
Cash Ratio?3.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
92
1.25CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-209.1%WEAK▾
ROA?
S&P
3
-148.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$46.1K
Fundamentals ratios updated end of day
MarketsMoversWatchlist